Search

 


Results 1-25 of 143.
 |   | 
JRC N°Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)
JRC660542012Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer modelGUSTAFSSON Anna; BAECK Tom; ELGQVIST Joergen; JACOBSSON Lars; HULTBORN Ragnar; ALBERTSSON Per; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; JENSEN Holger; LINDEGREN Sture
JRC655342012Treatment of early and established Cryptococcus neoformans infection with radiolabeled antibodies in immunocompetent miceJIANG Z.; BRYAN R. A.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; Casadevall Arturo; DADACHOVA E.
JRC488352008Production of Alpha Emitting Radionuclides for Nuclear MedicineMORGENSTERN Alfred; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank
JRC556832009Radioimmunotherapy of human bladder cancer in a nude mouse model comparing Bi-213-anti-EGFR-MAb and Th-226-anti-EGFR-MAbPFOST B.; MORGENSTERN Alfred; SEIDL C.; BRUCHERTSEIFER Frank; AUTENRIETH M.; APOSTOLIDIS Christos; ABBAS Kamel; SENEKOWITSCH-SCHMIDTKE R.
JRC549002010Investigation of Para-sulfonatocalix[n]arenes [n = 6, 8] as Potential Chelates for 230UMONTAVON Gilles; REPINC Urska; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; ABBAS Kamel; MORGENSTERN Alfred
JRC485292008Bismuth-213 Radioimmunotherapy with C595 Anti¿MUC1 Monoclonal Antibody in an Ovarian Cancer Ascites ModelSONG E.; QU C. F.; RIZVI S.; RAJA C.; BERETOV J.; MORGENSTERN Alfred; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; PERKINS A. D.
JRC556822009Therapeutic efficacy of intravesical -radioimmunotherapy with Bi-213-anti-EGFR-MAb in a human bladder cancer nude mouse modelPFOST B.; SEIDL C.; AUTENRIETH M.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SENEKOWITSCH-SCHMIDTKE R.
JRC556842009Analysis of DNA double-strand breaks in gastric cancer cells after treatment with 213Bi-immunoconjugatesSEIDL C.; FRANK Annette; PFOST B.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SENEKOWITSCH-SCHMIDTKE Reingard
JRC573722010[An(H2O)9](CF3SO3)3 (An=U-Cm, Cf): Exploring Their Stability, Structural Chemistry, and Magnetic Behavior by Experiment and TheoryAPOSTOLIDIS Christos; SCHIMMELPFENNIG Bernd; MAGNANI Nicola; LINDQVIST-REIS Patric; WALTER Olaf; SYKORA Richard; MORGENSTERN Alfred; COLINEAU Eric; CACIUFFO Roberto; KLENZE R.; HAIRE Richard; REBIZANT J.; BRUCHERTSEIFER Frank; FANGHAENEL Thomas
JRC574222010Radioimmunotherapy is More Effective than Antifungal Treatment in Experimental Cryptococcal InfectionBRYAN R. A.; JIANG Z.; HOWELL Roberta; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; CASADEVALL A.; DADACHOVA E.
JRC563132010Immunoliposomal Delivery of 213Bi for Alpha-emitter Targeting of Metastatic Breast CancerLINGAPPA M.; SONG H.; THOMPSON S.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SGOUROS G.
JRC566372010Targeted Alpha-Radionuclide Therapy of Functionally Critical Located Gliomas with 213Bismuth-DOTA-[Thi8,Met(O2)11]-Substance P - A Pilot TrialCORDIER D.; FORRER F.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; GOOD S.; MÜLLER-BRAND J.; MÄCKE H.; REUBI Jean-Claude; MERLO A.
JRC655352013213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple MyelomaCHEREL M.; GOUARD S.; GASCHET J; SAÏ-MAUREL C; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; BOURGEOIS N.; GESTIN J.-f.; KRAEBER BODÉRÉ F; BARBET J; Moreau P; DAVODEAU F.
JRC804992013Radioimmunotherapy of Cryptococcus neoformans Spares Bystander Mammalian CellsBRYAN R. A.; JIANG Z.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; Casadevall Arturo; DADACHOVA E.
JRC808262013Functionalized NaA Nanozeolites Labeled with 224,225Ra for Targeted Alpha TherapyAGATA Piotrowska; EDYTA Leszczuk; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; BILEWICZ Aleksander
JRC709082012Measurement of the 225Ac half-lifePOMME Stefaan; MAROULI MARIA; SULIMAN GABRIEL; DIKMEN HASAN; VAN AMMEL Raf; JOBBAGY VIKTOR; DIRICAN A.; STROH HEIKO; PAEPEN Jan; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; MORGENSTERN Alfred
JRC808272013DNA double strand break assessment as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor radiotherapyGRAF Franziska; FAHRER Jörg; MAUS Stephan; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; VENKATACHALAM S.; FOTTNER C.; WEBER Matthias M.; HUELSENBECK Johannes; SCHRECKENBERGER M; KAINA B; MIEDERER Matthias
JRC811682013High Resolution microSPECT imaging of Bi-213DE SWART J; SEGBERS M; MORGENSTERN Alfred; VAN DER HAVE F; CHAN Ho-Sze; BERNDSEN S.c.; BRUCHERTSEIFER Frank; DE JONG Marion; BEEKMAN F.j.; KONIJNENBERG M.w.
JRC827112013Targeted alpha therapy of glioblastoma multiforme: initial clinical experience with 213Bi-substance PMORGENSTERN Alfred; KROLICKI Leszek; KUNIKOWSKA Jolanta; KOZIARA H; KROLICKI B; JAKUCINSKI M; MIKOŁAJCZAK Renata; PAWLAK Dariusz; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank
JRC831802014213Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cellsPICKHARD Anja; PIONTEK Guido; SEIDL C.; KOPPING Samuel; BLECHERT B.; MISSLBECK Martin; BROCKHOFF Gero; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.
JRC805022014Retention studies of recoiling daughter nuclides of 225Ac in polymer vesiclesWANG G.; DE KRUIJFF R. M.; ROL A; THIJSSEN L.; MENDES E; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; STUART M.c.a.; WOLTERBEEK H.th.; DENKOVA A.g.
JRC680422012Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosisESSLER M.; GAERTNER F. C.; NEFF Frauke; BLECHERT B.; SENEKOWITSCH-SCHMIDTKE R.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SEIDL C.
JRC827422013Development of a high-activity 225Ac/213Bi radionuclide generator for synthesis of clinical doses of 213Bi-labelled biomoleculesBRUCHERTSEIFER Frank; APOSTOLIDIS Christos; MIRZADEH Saed; BOLL Rose; MURPHY Karen; MORGENSTERN Alfred
JRC827972013Retention studies in polymer vesicles of recoiling atoms as a result of alpha decayWANG G.; VAN BUEREN J; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; WOLTERBEEK H.th.; MENDES E; DENKOVA A.g.
JRC831792014DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapyGRAF Franziska; FAHRER Jörg; MAUS Stephan; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; VENKATACHALAM S.; FOTTNER C.; WEBER M.m.; HUELSENBECK Johannes; SCHRECKENBERGER M; KAINA B; MIEDERER Matthias